573 related articles for article (PubMed ID: 19379613)
1. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients.
Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C
Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613
[TBL] [Abstract][Full Text] [Related]
2. Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis.
Folz BJ; Wollstein AC; Lippert BM; Werner JA
Am J Rhinol; 2005; 19(1):65-70. PubMed ID: 15794077
[TBL] [Abstract][Full Text] [Related]
3. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
Mahoney EJ; Shapshay SM
Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
[TBL] [Abstract][Full Text] [Related]
4. Lack of significant estrogen and progesterone receptor expression in nasal telangiectasias in hereditary hemorrhagic telangiectasia: an immunohistochemical analysis.
Eivazi B; Werner JA; Roessler M; Negm H; Teymoortash A
Acta Otolaryngol; 2012 Jan; 132(1):86-9. PubMed ID: 22185213
[TBL] [Abstract][Full Text] [Related]
5. [Argon plasma coagulation and topically applied estriol. Long-term results in the treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa].
Sadick H; Riedel F; Oulmi J; Hörmann K; Bergler WF
HNO; 2003 Feb; 51(2):118-24. PubMed ID: 12589417
[TBL] [Abstract][Full Text] [Related]
6. Natural history and control of epistaxis in a group of German patients with Rendu-Osler-Weber disease.
Folz BJ; Tennie J; Lippert BM; Werner JA
Rhinology; 2005 Mar; 43(1):40-6. PubMed ID: 15844501
[TBL] [Abstract][Full Text] [Related]
7. Contact endoscopy of the nose in patients with Rendu-Osler-Weber syndrome.
Folz BJ; Werner JA
Auris Nasus Larynx; 2007 Mar; 34(1):45-8. PubMed ID: 17134864
[TBL] [Abstract][Full Text] [Related]
8. Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleeds.
Pagella F; Matti E; Chu F; Pusateri A; Tinelli C; Olivieri C; Canzonieri C; Boeri L; Ornati F; Danesino C
Acta Otolaryngol; 2013 Feb; 133(2):174-80. PubMed ID: 23066781
[TBL] [Abstract][Full Text] [Related]
9. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
Hanks JE; Hunter D; Goding GS; Boyer HC
Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
[TBL] [Abstract][Full Text] [Related]
10. Clinical Practice Guideline: Nosebleed (Epistaxis).
Tunkel DE; Anne S; Payne SC; Ishman SL; Rosenfeld RM; Abramson PJ; Alikhaani JD; Benoit MM; Bercovitz RS; Brown MD; Chernobilsky B; Feldstein DA; Hackell JM; Holbrook EH; Holdsworth SM; Lin KW; Lind MM; Poetker DM; Riley CA; Schneider JS; Seidman MD; Vadlamudi V; Valdez TA; Nnacheta LC; Monjur TM
Otolaryngol Head Neck Surg; 2020 Jan; 162(1_suppl):S1-S38. PubMed ID: 31910111
[TBL] [Abstract][Full Text] [Related]
11. Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial.
Riss D; Burian M; Wolf A; Kranebitter V; Kaider A; Arnoldner C
Head Neck; 2015 Jun; 37(6):783-7. PubMed ID: 24595923
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
[TBL] [Abstract][Full Text] [Related]
13. Narrow-band imaging in the endoscopic evaluation of hereditary hemorrhagic telangiectasia patients.
Pagella F; Pusateri A; Chu F; Caputo M; Danesino C; Matti E
Laryngoscope; 2013 Dec; 123(12):2967-8. PubMed ID: 23929661
[No Abstract] [Full Text] [Related]
14. Intractable epistaxis due to isolated primary telangiectasias.
Stoddard T; Loehrl TA; Hunt BC; Poetker DM
JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):160-3. PubMed ID: 24337437
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
[TBL] [Abstract][Full Text] [Related]
16. [Intractable epistaxis in Osler-Rendu-Weber syndrome].
Zalagh M; Errami N; Bouaity B; Hemmaoui B; Itoua W; Benariba F
Rev Stomatol Chir Maxillofac; 2011 Nov; 112(5):310-2. PubMed ID: 21940027
[TBL] [Abstract][Full Text] [Related]
17. Hereditary hemorrhagic telangiectasia: a review of 76 cases.
Shah RK; Dhingra JK; Shapshay SM
Laryngoscope; 2002 May; 112(5):767-73. PubMed ID: 12150604
[TBL] [Abstract][Full Text] [Related]
18. Hereditary haemorrhagic telangiectasia.
Sharathkumar AA; Shapiro A
Haemophilia; 2008 Nov; 14(6):1269-80. PubMed ID: 19141168
[TBL] [Abstract][Full Text] [Related]
19. [Nd:YAG laser therapy of recurrent epistaxis in hereditary hemorrhagic telangiectasia].
Werner JA; Lippert BM; Geisthoff UW; Rudert H
Laryngorhinootologie; 1997 Aug; 76(8):495-501. PubMed ID: 9376034
[TBL] [Abstract][Full Text] [Related]
20. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
Hitchings AE; Lennox PA; Lund VJ; Howard DJ
Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
